Crispr Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.1M | 24k | 47.01 |
| 2024-06-30 | $23M | 421k | 54.02 |
| 2024-03-31 | $41M | 600k | 68.16 |
| 2023-12-31 | $54M | 864k | 62.60 |
| 2023-09-30 | $40M | 870k | 45.39 |
| 2023-06-30 | $50M | 882k | 56.14 |
| 2023-03-31 | $50M | 1.1M | 45.23 |
| 2022-12-31 | $46M | 1.1M | 40.65 |
| 2022-03-31 | $73M | 1.2M | 62.77 |
| 2021-12-31 | $83M | 1.1M | 75.78 |
| 2021-09-30 | $133M | 1.2M | 111.93 |
| 2021-06-30 | $193M | 1.2M | 161.89 |
| 2021-03-31 | $158M | 1.3M | 121.85 |
| 2020-12-31 | $272M | 1.8M | 153.11 |
| 2020-09-30 | $136M | 1.6M | 83.64 |
| 2020-06-30 | $101M | 1.4M | 73.49 |
| 2020-03-31 | $43M | 1.0M | 42.41 |
| 2019-12-31 | $68M | 1.1M | 60.90 |
| 2019-09-30 | $29M | 698k | 40.99 |
| 2019-06-30 | $35M | 739k | 47.10 |
| 2019-03-31 | $22M | 618k | 35.72 |
| 2018-12-31 | $18M | 616k | 28.57 |
| 2018-09-30 | $9.0M | 203k | 44.35 |
| 2018-06-30 | $12M | 200k | 58.76 |